Dextromethorphan found to have potential in treating lung fibrosis

A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.

FDA expands label for Novartis and Roche’s blockbuster, converts EMD Serono’s NSCLC drug to full approval

The FDA on Friday signed off on an expanded label for Novartis and Roche’s blockbuster Xolair (omalizumab) and on Thursday converted the accelerated to full

February 17, 2024

Sumitomo Pharma’s DSP-5336 gains FDA fast track for AML

The ongoing clinical evaluation of DSP-5336’s safety and efficacy is part of a Phase I/II dose escalation/dose expansion study. Credit: Nuttapong punna/Shutterstock. The US Food

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Dextromethorphan found to have potential in treating lung fibrosis

Yourgene Health advances cystic fibrosis testing with IVDR compliance

FDA expands label for Novartis and Roche’s blockbuster, converts EMD Serono’s NSCLC drug to full approval

Sumitomo Pharma’s DSP-5336 gains FDA fast track for AML

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe